Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 10015-10023
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10015
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10015
Table 6 Comparison according to diagnosis
| Doubling time (mo), median | P value | |
| GIST vs Leiomyoma + schwannoma | 17.2 vs 204.2 | 0.005 |
| High risk vs Intermediate risk | 3.9 vs 17.1 | 0.127 |
| Intermediate risk vs Extremely low + low risk | 17.1 vs 24.0 | 0.423 |
| High risk vs Extremely low + low risk | 3.9 vs 24.0 | 0.033 |
| High + intermediate risk vs Extremely low + low risk | 8.2 vs 24.0 | 0.047 |
- Citation: Koizumi S, Kida M, Yamauchi H, Okuwaki K, Iwai T, Miyazawa S, Takezawa M, Imaizumi H, Koizumi W. Clinical implications of doubling time of gastrointestinal submucosal tumors. World J Gastroenterol 2016; 22(45): 10015-10023
- URL: https://www.wjgnet.com/1007-9327/full/v22/i45/10015.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i45.10015